NoviPel (2014) is a MedTech company with the aim of treating urinary incontinence (UI). An estimated 10% of all women, i.e. more than 300,000 women in Denmark, suffer from UI. The condition is still widely considered a taboo and has no effective treatment today. Sundhedsstyrelsen recommends the following treatments by order of effectiveness: Pelvic floor muscle training (PFMT); pharmacological therapy; and surgery. Surgery, used as a last resort solution, is expensive and has poor response rates. Pharmacological therapy has shown slightly better response rates but is accompanied by non-negligible side-effects. PFMT is a highly individual and specialized procedure. Done correctly it is a cheap, non-invasive procedure void of side-effects. There is a proven need for a tool to allow healthcare practitioners (HCPs) to standardize treatment, teach correct exercises, and collect data accurately. Our device is a non-invasive vaginal probe, offering users a new, data-driven best practice of supervised PFMT, AI nudging to improve adherence and patient education. The fully automated method optimizes existing treatment methods and improves HCP’s in their workflow. Our device can directly decrease existing UI related health economic costs by mitigating expenses from diapers and surgery-related expenses.